EW Stock Analysis: Buy, Sell, or Hold?
EW - Edwards Lifesciences Corp
$86.95
1.07 (1.25%)
▲
5d:
+0.78%
30d:
+4.51%
90d:
+6.01%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 23, 2026
29d
Smart Money Accumulation
None View Scanner →
Strength: 5.4/10
Get Alerted When EW Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: EW shows positive signals but monitor for confirmation. Market pricing in 0.6% decline. Moderate conviction.
💡 BUY OPPORTUNITY: EW shows positive signals but monitor for confirmation. Market pricing in 0.6% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$123.49
Based on 8.0% avg growth
INTRINSIC VALUE TODAY
$76.68
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EW is currently trading at $86.95, which is considered slightly high relative to its 30-day fair value range of $83.96 to $87.70. The stock's valuation (Forward PE: 25.8) is in line with its historical norms (26.3). Remarkably, the market is currently pricing in an annual earnings decline of 0.6% over the next few years. This pessimistic expectation contrasts with the company's recent 8.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, EW is in a uptrend. Immediate support is located at $83.17, while resistance sits at $89.60.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $96.92 (+11.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EW is in a uptrend. Immediate support is located at $83.17, while resistance sits at $89.60.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $96.92 (+11.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$83.96 -
$87.70
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
62.9%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($96.92)
Trading Range Analysis
30-Day Trading Range
$83.96 -
$87.70
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$83.17
Resistance Level
$89.60
Current Trend
Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.82
Wall Street Target
$96.92
(+11.5%)
Revenue Growth (YoY)
16.7%
Earnings Growth (YoY)
8.2%
Profit Margin
17.4%
Valuation Discount vs History
-0.6% cheaper
PE vs Historical
25.8 vs 26.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.6%
(market-implied from PE analysis)
1-Year Target
$86.43
(-1%)
2-Year Target
$85.91
(-1%)
3-Year Target
$85.39
(-2%)
3-Yr Target (if PE normalizes)
(PE: 26→26)
$86.99
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.8, Growth: 12.0%)
$122.09
(+40%)
Base:
(SPY PE: 21.8, Growth: 12.0%)
$103.00
(+19%)
Bear:
(PE: 18.5, Growth: 12.0%)
$87.55
(+1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (47x PE), but valuation improves significantly next year (26x PE) as earnings recover.
Trailing PE: 47.22 | Current EPS (TTM): $1.85
Bull Case
$174.93
(+104%)
Analyst growth 82.0%, PE expands to 51.9
Base Case
$159.03
(+85%)
Market implied 82.0%, PE stable at 47.2
Bear Case
$59.40
(-31%)
Severe decline -20.0%, PE contracts to 40.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 25.8 to 26.3
Stabilization Target:
$88.57
(+1.9%)
PE Expansion Potential:
+1.9%
Share & Embed Analysis
Last updated: June 23, 2026 5:51 PM ET
Data refreshes hourly during market hours. Next update: 6:51 PM
Data refreshes hourly during market hours. Next update: 6:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EW showing a specific setup today?
Insider Activity (6 Months)
1
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott B Ullem
SELL
13000 shares
2026-04-09
Daniel J Lippis
SELL
1019 shares
2026-04-06
Donald E Bobo Jr
SELL
22680 shares
2026-04-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 61 BUY |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 62 BUY |
Advanced EW Option Strategies
Professional options setups generated by AI based on today's EW price and gamma walls.
